SureTrader
Home > Boards > US Listed > Medical - Healthcare > SurModics (SRDX)

>BTW - This is different than a discussion

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 672
Posts 102,334
Boards Moderated 25
Alias Born 09/05/02
160x600 placeholder
Additional Proxy Soliciting Materials (definitive) (defa14a) "Edgar (US Regulatory)" - 1/4/2018 5:15:37 PM
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 1/4/2018 5:12:34 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 12/19/2017 5:47:34 PM
Annual Report (10-k) "Edgar (US Regulatory)" - 12/1/2017 5:34:42 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/8/2017 7:46:43 AM
Surmodics Reports Fourth Quarter Fiscal 2017 Results and Provides Fiscal 2018 Guidance "Business Wire" - 11/8/2017 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 11/3/2017 4:31:57 PM
Surmodics to Present at Canaccord Genuity Medical Technologies and Diagnostics Forum "Business Wire" - 10/26/2017 4:05:00 PM
Surmodics to Webcast Fourth Quarter 2017 Earnings Conference Call on November 8 "Business Wire" - 10/26/2017 8:00:00 AM
Surmodics Announces First Patient Enrolled in TRANSCEND Pivotal Clinical Trial for SurVeil® Drug-Coated Balloon "Business Wire" - 10/23/2017 8:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/3/2017 5:10:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/28/2017 4:56:43 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/28/2017 4:55:25 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/19/2017 4:10:47 PM
Surmodics Announces Global Approvals of .014" Low-Profile PTA Balloon Dilation Catheter "Business Wire" - 9/18/2017 8:00:00 AM
Six-Month Data from the Surmodics SurVeil® Drug-Coated Balloon Early Feasibility Study Presented at VIVA 2017 "Business Wire" - 9/13/2017 7:06:00 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 9/13/2017 5:04:10 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/15/2017 8:31:39 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 8/9/2017 4:58:12 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 8/3/2017 1:00:51 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 8/3/2017 7:46:21 AM
Surmodics Reports Third Quarter Fiscal 2017 Results and Updates Fiscal 2017 Guidance "Business Wire" - 8/3/2017 7:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/26/2017 8:16:26 AM
Surmodics Receives IDE Approval to Initiate Pivotal Trial of the SurVeil™ Drug-Coated Balloon "Business Wire" - 7/26/2017 8:00:00 AM
Surmodics to Webcast Third Quarter 2017 Earnings Conference Call on August 3 "Business Wire" - 7/25/2017 8:00:00 AM
DewDiligence Member Level  Tuesday, 01/23/07 08:15:44 AM
Re: iwfal post# 913
Post # of 2441 
>BTW - This is different than a discussion about whether to DES or to BMS<

Very much so, although there’s a tie-in to that debate concerning the degree to which restenosis ought to be treated without intervention.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist